Oct 15, 2025 20:08
MRK - Merck & Co., Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
84.92 -0.83 (-0.98%) | --- | --- | --- | -0.82 (-0.97%) | -0.07 (-0.08%) | -0.02 (-0.02%) | -0.02 (-0.02%) |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Earnings & Ratios
- Basic EPS:
- 1.76
- Diluted EPS:
- 1.76
- Basic P/E:
- 47.7785
- Diluted P/E:
- 47.7785
- RSI(14) 1m:
- 0.0
- VWAP:
- 84.09
- RVol:
- 0.5733
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Oct 15, 2025 16:23
Oct 14, 2025 15:41
Oct 13, 2025 10:10
Oct 12, 2025 17:05
Oct 10, 2025 13:00
Oct 08, 2025 18:59
Oct 07, 2025 18:02
Oct 06, 2025 20:05
Oct 06, 2025 15:00